Liposome possesses a great number of advantages and therefore they can be used for a
variety of applications. Among other things, they can serve as useful drug carriers in …

Surface functionalization of liposomes can play a key role in overcoming the current
limitations of nanocarriers to treat solid tumors, ie, biological barriers and physiological …

Gemcitabine, an anticancer agent which acts against a wide range of solid tumors, is known
to be rapidly deaminated in blood to the inactive metabolite 2′, 2′-difluorodeoxyuridine …

Nano-based delivery systems have attracted a great deal of attention in the past two
decades as a strategy to overcome the low therapeutic index of conventional anticancer …

There are many problems directly correlated with the systemic administration of drugs and
how they reach their target site. Targeting promises to be a hopeful strategy as an improved …

In this Letter, we varied targeting ligand density of an EGFR binding affibody on the surface
of two different hydrogel PRINT nanoparticles (80 nm× 320 and 55 nm× 60 nm) and …

Non-small cell lung cancer (NSCLC) is a serious threat to human health, and 40%–80% of
NSCLCs express high levels of epidermal growth factor receptor (EGFR). GE11 is a novel …

How to actively target tumor sites manipulating the controllable release of the encapsulated
anticancer drugs and photosensitizers for synergistic anticancer therapy remains a big …

The research and development of non-viral gene therapy has been extensive over the past
decade and has received a big push thanks to the recent successful approval of non-viral …

Nanoparticle mediated delivery of antineoplastic agents, functionalized with monoclonal
antibodies has achieved extraordinary potential in cancer therapy. The objective of this …